NCT05133947View on ClinicalTrials.gov

Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

June 30, 2022

Conditions
Peripheral Nervous System Diseases
Interventions
OTHER

Non interventional

Non interventional

Trial Locations (1)

Unknown

Bethune First Hospital Of Jilin University, Jilin

All Listed Sponsors
lead

Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

INDUSTRY

NCT05133947 - Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN | Biotech Hunter | Biotech Hunter